KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organon (OGN) Accounts Payables (2020 - 2025)

Organon has reported Accounts Payables over the past 6 years, most recently at $952.0 million for Q4 2025.

  • Quarterly results put Accounts Payables at $952.0 million for Q4 2025, down 17.43% from a year ago — trailing twelve months through Dec 2025 was $952.0 million (down 17.43% YoY), and the annual figure for FY2025 was $952.0 million, down 17.43%.
  • Accounts Payables for Q4 2025 was $952.0 million at Organon, down from $1.1 billion in the prior quarter.
  • Over the last five years, Accounts Payables for OGN hit a ceiling of $1.8 billion in Q2 2021 and a floor of $264.0 million in Q1 2021.
  • Median Accounts Payables over the past 5 years was $1.1 billion (2022), compared with a mean of $1.1 billion.
  • Biggest five-year swings in Accounts Payables: surged 433.59% in 2021 and later crashed 38.55% in 2022.
  • Organon's Accounts Payables stood at $1.4 billion in 2021, then fell by 18.09% to $1.1 billion in 2022, then grew by 16.08% to $1.3 billion in 2023, then decreased by 12.25% to $1.2 billion in 2024, then dropped by 17.43% to $952.0 million in 2025.
  • The last three reported values for Accounts Payables were $952.0 million (Q4 2025), $1.1 billion (Q3 2025), and $1.1 billion (Q2 2025) per Business Quant data.